Meeting Report

Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know

Mailey L. Wilks, DNP, APRN, NP-C

From Cleveland Clinic Cancer Institute, Ohio

Presenter’s disclosure of conflicts of interest is found at the end of this article.


J Adv Pract Oncol 2022;13(3):253–256 | https://doi.org/10.6004/jadpro.2022.13.3.14 | © 2022 Harborside™


  

ABSTRACT

Patients with cancer are at high risk for developing cancer-associated blood clots. Mailey L. Wilks, DNP, APRN, NP-C, led a session at JADPRO Live Virtual 2021 on the risk of venous thromboembolism in patients with cancer, available anticoagulants, with a focus on direct oral anticoagulants, and what advanced practitioners should know about the prevention and the treatment of venous thromboembolism.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2022 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.